{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:54:05Z","timestamp":1774648445370,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jogoh.2021.102173","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T02:19:24Z","timestamp":1622427564000},"page":"102173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of ulipristal acetate in women with fibroid induced menorrhagia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"50","author":[{"given":"Georgios","family":"Kounidas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavroula Lila","family":"Kastora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Barnott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Robinson-Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Gould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Urquhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amudha","family":"Poobalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Jack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jogoh.2021.102173_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.43","article-title":"Uterine fibroids","volume":"2","author":"Stewart","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.jogoh.2021.102173_bib0002","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13669-016-0162-2","article-title":"Fibroids and infertility","volume":"5","author":"Purohit","year":"2016","journal-title":"Curr Obstet Gynecol Rep"},{"issue":"4","key":"10.1016\/j.jogoh.2021.102173_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.07.017","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"209","author":"Borah","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2021.102173_bib0004","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejogrb.2018.07.032","article-title":"Impact of uterine fibroids on quality of life: a national cross-sectional survey","volume":"229","author":"Fernandez","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"14","key":"10.1016\/j.jogoh.2021.102173_bib0005","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N Engl J Medicine"},{"key":"10.1016\/j.jogoh.2021.102173_bib0006","unstructured":"European Medicines Agency. PRAC recommends new measures to minimise risk of rare but serious liver injury with Esmya for fibroids, https:\/\/www.ema.europa.eu\/en\/news\/prac-recommends-new-measures-minimise-risk-rare-serious-liver-injury-esmya-fibroids [accessed 22nd May 2020]."},{"key":"10.1016\/j.jogoh.2021.102173_bib0007","unstructured":"European Medicines Agency. Ulipristal acetate 5 mg for uterine fibroids not to be used during ongoing review of liver injury risk. https:\/\/www.ema.europa.eu\/en\/medicines\/dhpc\/ulipristal-acetate-5-mg-uterine-fibroids-not-be-used-during-ongoing-review-liver-injury-risk [accessed 22nd May 2020]."},{"key":"10.1016\/j.jogoh.2021.102173_bib0008","unstructured":"European Medicines Agency. Ulipristal acetate for uterine fibroids: EMA recommends restricting use. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/ulipristal-acetate-5mg-medicinal-products [accessed 20th January 2021]."},{"key":"10.1016\/j.jogoh.2021.102173_bib0009","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogoh.2021.102173_bib0010","first-page":"366","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jogoh.2021.102173_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"issue":"5","key":"10.1016\/j.jogoh.2021.102173_bib0012","doi-asserted-by":"crossref","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jogoh.2021.102173_bib0013","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2010.09.059","article-title":"Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study","volume":"95","author":"Nieman","year":"2011","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.jogoh.2021.102173_bib0014","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/AOG.0000000000002462","article-title":"Ulipristal acetate for treatment of symptomatic uterine leiomyomas: a randomized controlled trial","volume":"131","author":"Simon","year":"2018","journal-title":"Obstet. Gynecol"},{"issue":"1","key":"10.1016\/j.jogoh.2021.102173_bib0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/rmb2.12304","article-title":"Ulipristal acetate for Japanese women with symptomatic uterine fibroids: a double-blind, randomized, phase II dose-finding study","volume":"19","author":"Irahara","year":"2020","journal-title":"Reprod Med Biol"},{"key":"10.1016\/j.jogoh.2021.102173_bib0016","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N. Engl J Med"},{"issue":"5","key":"10.1016\/j.jogoh.2021.102173_bib0017","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/AOG.0000000000002942","article-title":"Ulipristal acetate for treatment of uterine leiomyomas: a randomized controlled trial","volume":"132","author":"Liu","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jogoh.2021.102173_bib0018","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ijgo.12868","article-title":"A systematic review and meta-analysis of ulipristal acetate for symptomatic uterine fibroids","volume":"146","author":"Ghonim","year":"2019","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784721001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784721001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:58:48Z","timestamp":1762855128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784721001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2468784721001112"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2021.102173","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of ulipristal acetate in women with fibroid induced menorrhagia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2021.102173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102173"}}